JOAN - Hot Stocks: JOAN drops on earnings; TPTX soars on takeover deal; NVAX plunges; COP sets high

Wall Street suffered renewed selling on Friday, as worries about the economy and interest rates resurfaced. Stronger-than-expected job statistics raised fears that the Federal Reserve would remain aggressive about raising interest rates. Meanwhile, Elon Musk sounded the latest in a series of high-profile warnings about the economy, saying he had a "super bad feeling." Looking at individual stocks, Novavax (NVAX) lost around a fifth of its value amid concerns about the connection between its COVID vaccine and myocarditis. Meanwhile, JOANN (JOAN) plunged to a new 52-week low following a disappointing earnings report. On the other side of the ledger, shares of Turning Point Therapeutics (NASDAQ:TPTX) more than doubled following the announcement of a merger deal with Bristol Myers (BMY).  At the same time, ConocoPhillips (COP) set a new 52-week peak, riding higher on a further rise in oil prices. Standout Gainer Turning Point Therapeutics (TPTX) surged following the announcement of

For further details see:

Hot Stocks: JOAN drops on earnings; TPTX soars on takeover deal; NVAX plunges; COP sets high